Analyst firms · Barclays · IQV
Barclays IQV price target and rating history
IQVIA Holdings Inc. (IQV) · Health Care
Barclays rates IQVIA Holdings Inc. (IQV) Overweight with a $210 price target, as of its latest action on Mar 6, 2026. It has published 4 rating actions on IQV since July 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Barclays's $210 is 1% below that.
- Current rating
- Overweight
- Price target
- $210
- Median target, all firms
- $213
- Actions on IQV
- 4
Barclays price target on IQV
Every Barclays rating on IQV
- Mar 6, 2026
- Apr 10, 2025
- Oct 25, 2021
- Jul 13, 2021
How other firms rate IQV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $345 | Sep 30, 2026 |
| Morgan Stanley | Equal-Weight | $200 | Jun 17, 2026 |
| TD Cowen | Buy | $213 | Mar 9, 2026 |
| Barclays | Overweight | $210 | Mar 6, 2026 |
| RBC Capital Markets | Outperform | $221 | Mar 3, 2026 |
Questions about Barclays and IQV
- What is Barclays's price target for IQV?
- Barclays's latest stated price target for IQVIA Holdings Inc. (IQV) is $210, from its action on Mar 6, 2026.
- What is Barclays's rating on IQV?
- Barclays rates IQV Overweight, a bullish rating, as of Mar 6, 2026.
- When did Barclays last change its view on IQV?
- On Mar 6, 2026, Barclays upgrades to Overweight from Equal Weight, price target $210.
- How does Barclays's IQV target compare with other analysts?
- Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Barclays's $210 is 1% below that.
More IQV rating histories
All Barclays ratingsIQV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.